There are many relevant studies on the effect of CCR5 inhibition after stroke, but owing to the redundant manner in which chemokine families act, complex cellular and molecular changes after stroke, and differences in experimental methods and genetic backgrounds, the results of these studies vary to some extent. Here, CCR5 is linked to stroke disorder.